Time New York: Sat 01 Oct 14:57 pm  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Align Technology: Invisalign Growth Continues Globally

Zacks

On Sep 20, 2016, we issued an updated research report on California-based Align Technology Inc. ALGN, a developer of aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services. Currently, Align carries a Zacks Rank #2 (Buy).

Persistent strong Invisalign volume growth across the company’s entire customer base primarily continues to drive results for Align.

In the last reported quarter, geographically, Align was successful in delivering double-digit sales growth in North America as well as overseas. In North America, the company witnessed continued increase in utilization among its orthodontist customers that reached record levels in both ortho and GP channels.

In the international space too, the company delivered a strong performance across all countries. In the EMEA region, growth was led by Spain, France and the Netherlands. In Asia Pacific, strong expansion was observed in China, Japan, South Asia and Taiwan.


However, a vast majority of Align’s total net revenue is highly dependent on the sale of its Invisalign System and the same trend is expected to continue at least in the near future. Management fears that if consumer demand for Align’s orthodontic services somehow declines or consumers become averse to adopt Invisalign as rapidly as expected, the company’s business may be severely affected.

We are concerned about the ongoing economic uncertainty too, which casts a gloom on Align’s dental procedures as well. The competitive landscape also remains a major headwind.

Key Picks in the Sector

Some other top-ranked medical stocks worth a look are Antares Pharma Inc. ATRS, Derma Sciences Inc. DSCI and Merit Medical Systems, Inc. MMSI. All these stocks hold a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.